Skip to main content
. 2018 Aug 25;10(9):1164. doi: 10.3390/nu10091164

Figure 2.

Figure 2

The comparison of serum Wnt 10b level to the use of calcitriol in patients with skeletal bone resistance disease favored (Left, PTH > 300 pg/mL and ALP < 155 IU/L) and high bone turnover disease favored (Right, PTH > 300 pg/mL and ALP > 155 IU/L). Values are means ± SD. (Blue: No calcitriol; green: Calcitriol). Wnt 10b was significantly increased in both skeletal bone resistance disease group and high bone turnover disease group with calcitriol treatment. ** p < 0.01.